Strategies & Market Trends | Mr. Pink's Picks: selected event-driven value investments


Previous 10 | Next 10 
To: Mr. Pink who wrote (18236)8/29/2005 10:35:46 AM
From: tigertrader18   of 18829
 
Gross margin shortfall and soft growth at VISX should be near term anomalies in my opinion. Also strong dollar did not help Q2. May I assume you like it from the long side?

Share Recommend | Keep | Reply | Mark as Last Read

From: tigertrader188/29/2005 10:37:55 AM
   of 18829
 
Check out LI here, I think this is a layup here under $24. Back up the truck at $23. Using strong cash flow to buy back stock. Should be $28-29 by year end...

Share Recommend | Keep | Reply | Mark as Last Read

To: tigertrader18 who wrote (18235)9/10/2005 11:56:30 PM
From: Mr. Pink   of 18829
 
agreed

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (2)

From: tigertrader189/12/2005 9:11:11 AM
   of 18829
 
IVN starting to get some legs

Share Recommend | Keep | Reply | Mark as Last Read

From: Junglekings9/15/2005 8:43:01 PM
   of 18829
 
anyone like TBAC? looks cheap.

Share Recommend | Keep | Reply | Mark as Last Read

To: Mr. Pink who wrote (18240)9/16/2005 7:59:18 PM
From: kjhwang   of 18829
 
Anyone eyeing Whitehall Jewellers JWL? Severe market over reaction driving the stock to <2.

At ~100 mm EV and ~384 stores, current price translates into roughly 270k per store-clearly a grossly undervalued situation.

Share Recommend | Keep | Reply | Mark as Last Read

From: redgsr19/18/2005 10:05:25 PM
   of 18829
 
WSBL, big reversal underway undervalued and oversold.

Check out the chart the trend is your friend here for sure. BB tight and about to break out the top, Macd, Obv, and Rsi all pointing to major break on the way.

I am playing this 1-4 week swing price target over.1
We will see at least .05 this week IMO

Always do you DD

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)

From: catablast9/19/2005 2:19:27 AM
   of 18829
 
CVS - BUY RATING

Ever asked yourself: Should I own Walgreens (WAG) or Rite Aid (RAD)?

We certainly have, and we finally came up with an answer: "none of the above."

The drugstore chain you want to own here is CVS.

The recent Katrina-driven pulback in the stock has created what we believe is a wonderful buying opportunity.

CVS now owns more than 5,400 stores and it's an enterprise that's only going to get bigger.

The inclusion of revenues from the recently acquired Eckerd stores leaves CVS in good shape and well-equipped to benefit from continued growth in this industry.

While the fact that prescription drugs account for 80% of total CVS sales makes us a little edgy, we're going to kick off coverage with a Buy Rating.

The industry should experience strong growth as Baby Boomers enter their golden years and demand for prescription drugs rises.

The phalanx of generic drugs coming to market will boost CVS' numbers.

Then there's the expected acquisition synergies.

The key metric here is sales per square foot.

Sales per square foot of $356 for Eckerd stores vs. $834 in CVS -- if the integration goes smoothly, we think CVS' top line will show it.

We're expecting continued expansion of the company's store base, same store sales growth, and earnings acceleration over the next 12 months.

Plus, with CVS tucked away in your portfolio, you don't have to worry about what Greenspan and Co are going to do to interest rates.

One way or the other, people need their drugs.

And that means you need some CVS.

Share Recommend | Keep | Reply | Mark as Last Read

From: catablast9/19/2005 2:20:30 AM
   of 18829
 
BEST BUY A BUY

Sometimes the stock market will throw a sale at you.

If you're not poking around in the basment section of the Wall Street store, you could miss out on some really overlooked and undervalued items, like Best Buy.

Best Buy (BBY) was crushed on Tuesday after management lowered guidance and talk continued about higher gas price's effect on discretionary consumer spendng.

What that means for the "value "investor is that Best Buy is now at an attractive buying level.

How do you determine if a stock is getting unnecessarily clobbered?

I like to ask myself: Is the stock price deterioating much faster than the business (model) underneath it?

Best Buy the stock gets bullied around but Best Buy the enterprise remains a market leader.

I heard the conference call (twice) and I think management has its game together.

I'll take Best Buy over Walmart or Circuit City any day of the week.

BBY is 10 points off its 52 week high and we feel a regression to the mean is in order for the consumer retailer -- let's see what the holiday season has in store for it.

In light of Tuesday's selloff, we're issuing a short term Strong Buy Rating on Best Buy shares.

The middle class is finally beginning to feel the pain at the pump, but at the end of the day, mom still needs her camera phone and junior his coveted iPod nano.

Share Recommend | Keep | Reply | Mark as Last Read

From: catablast9/19/2005 2:26:29 AM
   of 18829
 
MO a Buy?





Send the suits home.

The cigarette litigation mess is over.

On Friday I spoke to a portfolio manager and friend at Morgan Stanley regarding the compelling Philip Morris/Altria research report the firm's David Adelman just put out.

Jim Cramer beat me to the punch, unfortunately; he profiled Altria on Friday night's taping of Mad Money.

Anyways, here is the skinny.

Adelman thinks Philip Morris (MO) is going to break up the company.

Adelman, a highly recognized tobacco analyst, is convinced the sum of Altria's parts is greater than its whole.

The stock is up more than 150% over the last 24 months, yet Adelman says Morris' enterprise value could fetch over $100 a share upon breakup.

It's a tough call.

I don't own MO -- but if I did -- I'd be painfully tempted to sell at least half my position here (depending more or less on my entry point).

On the other hand, a breakup in the near future is more plausible than you may think:

The research firm said Altria presents the most attractive risk-reward dynamic year-to-date in its industry, despite trading at close to an all-time high. Morgan Stanley believes the Avery and Watson court rulings have materially improved the industry's overall legal risk profile, making an Altria break-up significantly more likely.

However, Altria may decide to delay a breakup until there is greater clarity in the Justice Department lawsuit.

The capital markets should increasingly view an Altria break-up as only the first phase of a two-stage process...A break-up could ultimately be followed by a significant leveraging-up of Altria's and Phillip Morris' independent balance sheets.

We're going to shut up for once and forgo putting a rating on Altria until some more news develops.

Tough move, because deep down we really like Altria, especially that juicy 4% dividend.

Share Recommend | Keep | Reply | Mark as Last Read
Previous 10 | Next 10 

Copyright © 1995-2013 Knight Sac Media. All rights reserved.